Stocks and Investing
Stocks and Investing
Thu, January 7, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Michael Rose Maintained (SNV) at Buy with Increased Target to $40 on, Jan 7th, 2021
Michael Rose of Raymond James, Maintained "Synovus Financial Corp." (SNV) at Buy with Increased Target from $28 to $40 on, Jan 7th, 2021.
Michael has made no other calls on SNV in the last 4 months.
There are 2 other peers that have a rating on SNV. Out of the 2 peers that are also analyzing SNV, 0 agree with Michael's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Michael
- Steven Duong of "RBC Capital" Upgraded from Hold to Buy and Held Target at $40 on, Friday, December 11th, 2020
- Brody Preston of "Stephens & Co." Upgraded from Hold to Buy on, Thursday, October 22nd, 2020
Contributing Sources